modafinil
Generic: modafinil
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
modafinil
Generic Name
modafinil
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
TABLET
Routes
Active Ingredients
modafinil 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-873
Product ID
71610-873_2eaa44b1-463c-4195-e063-6294a90a0e60
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209966
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2019-02-15
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610873
Hyphenated Format
71610-873
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
modafinil (source: ndc)
Generic Name
modafinil (source: ndc)
Application Number
ANDA209966 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (71610-873-30)
- 60 TABLET in 1 BOTTLE (71610-873-53)
- 90 TABLET in 1 BOTTLE (71610-873-60)
- 180 TABLET in 1 BOTTLE (71610-873-80)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2eaa44b1-463c-4195-e063-6294a90a0e60", "openfda": {"nui": ["N0000175729", "N0000175651", "N0000175769"], "unii": ["R3UK8X3U3D"], "rxcui": ["205324"], "spl_set_id": ["2bc3cd03-2726-f693-e063-6294a90a7a03"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]"], "pharm_class_epc": ["Sympathomimetic-like Agent [EPC]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71610-873-30)", "package_ndc": "71610-873-30", "marketing_start_date": "20250220"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-873-53)", "package_ndc": "71610-873-53", "marketing_start_date": "20250113"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-873-60)", "package_ndc": "71610-873-60", "marketing_start_date": "20250220"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-873-80)", "package_ndc": "71610-873-80", "marketing_start_date": "20250220"}], "brand_name": "Modafinil", "product_id": "71610-873_2eaa44b1-463c-4195-e063-6294a90a0e60", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic-like Agent [EPC]"], "product_ndc": "71610-873", "dea_schedule": "CIV", "generic_name": "Modafinil", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Modafinil", "active_ingredients": [{"name": "MODAFINIL", "strength": "200 mg/1"}], "application_number": "ANDA209966", "marketing_category": "ANDA", "marketing_start_date": "20190215", "listing_expiration_date": "20261231"}